Amantadine in the treatment of neuroleptic-induced obesity in rats: Behavioral, endocrine and neurochemical correlates

Pharmacopsychiatry

Volumn 30, Issue 2, 1997, Pages 43-54

  Baptista, T ^a,b,c   Lopez M E ^a   Teneud, L ^a   Contreras, Q ^a   Alastre, T ^a   De Quijada, M ^a   Araujo De Baptista, E ^a   Alternus, M ^b   Weiss, S R B ^b   Musseo, E ^b   Paez X ^a   Hernandez L ^a  

^a UNIVERSIDAD DE LOS ANDES   (Venezuela)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c NONE   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; BROMOCRIPTINE; DOPAMINE; NEUROLEPTIC AGENT; SEROTONIN; SULPIRIDE;

ANIMAL EXPERIMENT; ARTICLE; FEMALE; INTRACEREBRAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 8244244611     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979482     Document Type: Article

References (59)

1. Ataya, K., A. Mercado, J. Kartaginer, J. Abbasi, K. S. Moghissi: Bone density and reproductive hormones in patients with neuroleptic-induced hyperprolactinemia. Fertil. & Steril. 50 (1988) 876-881
2. Baptista, T., L. Hernández: Influencia de los neurolépticos sobre el peso corporal. Resumenes de la 31 a Convención Anual de ASOVAC. Caracas, Venezuela (1983) pp. 104
3. 2 dopamine receptors involved? Pharmacol. Biochem. Behav. 27 (1987) 399-405
4. Baptista, T., M. A. Parada, E. Murzi: Puberty modifies sulpiride effects on body weight in rats. Neurosci. Lett. 92 (1988) 161-164
5. 2 dopamine receptors supersensitivity? Med. Hypoth. 30 (1989) 5-8
6. Baptista, T., L. Hernández, B. G. Hoebel: Systemic sulpiride increases dopamine metabolites in the lateral hypothalamus. Pharmacol. Biochem. Behav. 37 (1990) 533-537
7. Baptista, T., L. Teneud, L. Hernández: Enhancement of amphetamine anorexia after chronic administration of sulpiride. Pharmacol. Biochem. Behav. 45 (1993a) 45-49
8. Baptista, T., L. Teneud, Q. Contreras, J. L. Burguera, M. Burguera, L. Hernández: Effects of acute and chronic lithium treatment on amphetamine-induced dopamine increase in the nucleus accumbens and prefrontal cortex in rats as studied by microdialysis. J. Neural Trans. 94 (1993b) 75-89
9. Baptista, T., M. Altemus, E. de Baptista, S. R. B. Weiss, L. Hernández: Tamoxifen prevents neuroleptic-induced obesity in rats. Neurosci. Soc. Abs. 1994, pp. 1286
10. Baptista, T., L. Teneud, Q. Contreras, T. Alastre, J. L. Burguera, M. de Burguera, E. de Baptista, S. Weiss, L. Hernández: Lithium and body weight gain. Pharmacopsychiat. 28 (1995) 35-44
11. Beumont, P. J. V., M. G. Gelder, H. G. Friesen, G. W Harris, P. C. B. MacKinnon, B. M. Mandelbrote, D. H. Wiles: The effects of phenothiazines on endocrine function: 1 Patients with inappropriate lactation and amenorrhoea. Brit. J. Psychiat. 124 (1974) 413-419
12. Bernstein, J. G.: Psychotropic drug induced weight gain: mechanisms and management. Clin. Neuropharmacol. 11 (1988) S194-S206
13. Besser, G. M., M. O. Thorner: Prolactin and gonadal function. Path. Biol. 23 (1975) 779-782
14. Bleidner, W. E., J. B. Harmon, W. E. Hewes, T. E. Lynes, E. C. Hernmann: Absorption, distribution and excretion of amantadine hydrochloride. J. Pharmacol. Exper. Ther. 150 (1965) 484-490
15. Carvey, P. M., L. C. Kao, T. J. Zhang, R. L. Amdur, D. H. Lin, R. Singh, H. L. Klawans: Dopaminergic alterations in cotreatments attenuating haloperidol-induced hypersensitivity. Pharmacol. Biochem. Behav. 35 (1990) 291-300
16. Cohen, R., M. Fisher: Amantadine treatment of fatigue associated with multiple sclerosis. Arch. Neurol. 46 (1989) 676-680
17. Cooper, J. R., F. E. Bloom, R. H. Roth: The Biochemical Basis of Neuropharmacology. Oxford University Press, New York (1966) 171-192
18. Correa, N., L. A. Opler, S. R. Kay, B. Birmaher: Amantadine in the treatment of neuroendocrine side effects of neuroleptics. J. Clin. Psychopharmacol. 7 (1987) 91-95
19. Davis, J. M., J. T. Barter, J. Kane: Antipsychotic drugs. In: Kaplan, H. I., B. J. Sadock: Comprehensive Textbook of Psychiatry/V, Vol. II. Williams & Wilkins, Baltimore (1989) 1626
20. Dorevitch, A., R. Aronzon, M. Starck: Psychotic exacerbation attributed to low dose bromocriptine treatment of galactorrea and hyperprolactinemia. Acta. Obts. Gynecol. Scand. 70 (1991) 375-376
21. Dunn, M.: Post-polio fatigue treated with amantadine. Arch. Neurol. 48 (1991) 570
22. Fayez, M., H. H. Ahmed, S. K. Quadri: Inhibition of plasma prolactin in the rat by amantadine. Life Sci. 37 (1985) 1877-1880
23. Frye, P. E., S. F. Pariser, M. H. Kim, E. W. O'Shaughnessy: Bromocriptine associated with symptom exacerbation during neuroleptic treatment of schizoaffective schizophrenia. J. Clin. Psychiatry. 43 (1982) 252-253
24. Ganong, W.: Fisiologia Médica. Editorial El Manual Moderno, Mexico (1994) 301-340
25. Gerardo-Gettens, T, B. J. Moore, J. S. Stern, B. A. Horwitz: Prolactin stimulates food intake in a dose-dependent manner. Am. J. Physiol. 256 (1989) R 276-280
26. Gianutsos, G., S. Chute, J. P. Dunn: Pharmacological changes in dopaminergic systems induced by long term administration of amantadine. Eur. J. Pharmacol. 110 (1985) 357-361
27. Goodall, E., C. Oxtoby, R. Richards, G. Watkinson, D. Brown, T. Silverstone: A clinical trial of the efficacy and acceptability of D-fenfluramine in the treatment of neuroleptic-induced obesity. Brit. J. Psychiat. 153 (1988) 208-213
28. Hernández, L., B. G. Stanley, B. G. Hoebel: A small, removable microdialysis probe. Life Sci. 39 (1986) 2629-2637
29. Hoebel, B. G., L. Hernández, G. P. Mark, D. Schwartz, E. Pathos, J. M. Steckel, E. Stone: Brain microdialysis as a molecular approach to obesity: serotonin, dopamine, cyclic-AMP. In: Bray, E., D. Ricquier, B. M. Spiegelman: Obesity: towards a molecular approach. Wiley-Liss, New York (1990) 45-61
30. Johnson, R. D.: Opioid involvement in feeding behavior and the pathogenesis of certain eating disorders. Med. Hypotheses 45 (1995) 491-497
31. Kebabian, J. W, D. B. Calne: Multiple receptors for dopamine. Nature. 277 (1979) 93-96
32. Kornhuber, J., M. Weller: Amantadine and the glutamate hypothesis of schizophrenia. Experiences in the treatment of neuroleptic malignant syndrome. J. Neural. Trans. 92 (1993) 57-65
33. Krawczyk, Z., K. Lyson, A. Stawowy, H. Pisarek, H. Stepien: Effects of amantadine on prolactin secretion, pituitary DNA synthesis and 3 H-spiperone binding in male estrogen-treated rats. Neuroendocrinol. 51 (1990) 632-636
34. Kuppfermann, I.: Location of higher cognitive and affective functions: the association cortices. In: Kandel, E. R., J. H. Schwartz, T. M. Jesell: Principles of neuralscience. Elsevier Science Publishing Co, New York (1991) pp. 823-838
35. Lipton, M., P. S. Gallo: Simplified textbook of statistics. Monteray, CA: Brooks/Cole: (1973) chap. 5.
36. McNamara, P., R. Durso: Reversible pathologic jealousy (Othello syndrome) associated with amantadine. J. Geriatr. Psychiatry Neurol. 4 (1991) 157-159
37. Mello, N. K., J. H. Mendelson, J. M. Drieze, S. K. Teoh, M. L. Kelly, J. W. Sholar: Effects of dopamine on prolactin: interactions with cocaine self-administration by female rhesus monkeys. J. Pharmacol. Exper. Ther. 270 (1994) 1110-1120
38. Mizoguchi, K., H. Yokoo, M. Yoshida, T. Tanaka, M. Tanaka: Amantadine increases the extracellular dopamine levels in the striatum by re-uptake inhibition and by N-methyl-D-aspartate antagonism. Brain Res. 662 (1994) 255-258
39. Moore, B. J., T. Gerardo-Gettens, B. A. Horewitz, J. S. Stern: Hyperprolactinemia stimulates food intake in the female rat. Brain Res. Bull. 17 (1986) 563-569
40. Murzi, E., T. Baptista, L. Hernández: Hypothalamic sites affecting masticatory neurons in rats. Brain Res. Bull. 26 (1991) 321-325
41. Nestelbaum, Z., S. A. Siris, A. Rifkin, H. Klar, G. T. Reardon: Exacerbation of schizophrenia associated with amantadine. Am. J. Psychiatry 143 (1986) 1170-1171
42. Parada, M. A., L. Hernández, B. G. Hoebel: Sulpiride injections in the lateral hypothalamus induce feeding and drinking in rats. Pharmacol. Biochem. Behav. 30 (1988) 917-923
43. Parada, M. A., L. Hernández, X. Páez, T. Baptista, M. Puig de Parada, M. Quijada: Mechanism of the sulpiride-induced obesity. Pharmacol. Biochem. Behav. 33 (1989) 45-50
44. 2 satiety receptors in the body weight increase induced by systemic sulpiride. Physiol. Behav. 50 (1991) 1161-1165
45. Parada, M. A., L. Hernández, E. Degoma: Serotonin may play a role in the anorexia induced by amphetamine injections into the lateral hypothalamus. Brain. Res. 577 (1992) 218-225
46. Parkes, J. D., K. I. Zilkha, D. M. Calver: Controlled trial of amantadine hydrochloride in Parkinson's disease. Lancet. 1 (1970) 259-262
47. Paxinos, G., Ch. Watson: The rat brain in stereotaxic coordinates. Academic Press, San Diego (1986)
48. Peter, S. A., A. Autz, M. L. Jean-Simon: Bromocriptine-induced schizophrenia. J. Nat. Med. Assoc. 85 (1993) 700-701
49. Pike, R.: Cocaine withdrawal: an effective three-drug regimen. Postgrad. Med. 85 (1989) 115-121
50. Rego, M. D., E. L. Giller. Mania secondary to amantadine treatment of neuroleptic-induced hyperprolactinemia. J. Clin. Psychiatry 50 (1989) 143-144
51. Samanin, R., S. Garattini: Neurochemical mechanisms of action of anorectic drugs. Pharmacol. & Toxicol. 73 (1993) 63-68
52. Simpson, G., E. H. Pi, J. J. Sramek: Adverse effects of antipsychotic agents. Drugs 21 (1981) 138-151
53. Stanley, B. G., V. L. Willet, H. W. Donias, L. H. Ha, L. C. Spears: The lateral hypothalamus: a primary site mediating excitatory aminoacid-elicited eating. Brain Res. 630 (1993) 41-49
54. Toide, K.: Effects of amantadine on dopaminergic neurons in discrete regions of the rat brain. Pharm. Res. 7 (1990) 670-672
55. Tsai-Morris, C. H., M. Ghish, A. N. Hirshfield, P. M. Wise, A. M. H. Brodie: Inhibition of ovarian aromatase by prolactin in vivo. Biol. Reprod. 29 (1983) 342-346
56. Von Voigtlander, P. F., K. E. Moore: Dopamine release from the brain in vivo by amantadine. Science 194 (1971) 408-409
57. Vernier, V. G., J. B. Harmon, J. M. Stump, T. E. Lynes, J. P. Marvel, D. H. Smith: The toxicologie and pharmacologie properties of amantadine hydrochloride. Toxicol. Appl. Pharmacol. 15 (1969) 642-665
58. Wade, G. N., J. E. Schneider: Metabolic fuels and reproduction in female mammals. Neurosci. Biobehav. Rev. 16 (1992) 235-272
59. Zaldivar, H. M., G. Sanchez, J. R. Monroy, P. A. Serrano: Stimulation of the central dopaminergic receptor in essential hypertensive patients using amantadine. Arch. Inst. Cardiol. Mex. 57 (1987) 9-17